These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 33967773)

  • 41. Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19.
    Khan MSI; Khan MSI; Debnath CR; Nath PN; Mahtab MA; Nabeka H; Matsuda S; Akbar SMF
    Arch Bronconeumol (Engl Ed); 2020 Dec; 56(12):828-830. PubMed ID: 33994641
    [No Abstract]   [Full Text] [Related]  

  • 42. Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study.
    Fernández-de-Las-Peñas C; Guijarro C; Plaza-Canteli S; Hernández-Barrera V; Torres-Macho J
    Lung; 2021 Jun; 199(3):249-253. PubMed ID: 33993321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association Between Famotidine Use and Clinical Outcomes in Patients With COVID-19: Assessment of Available Evidence.
    Ma T; Wu M
    Am J Gastroenterol; 2021 Apr; 116(4):848-849. PubMed ID: 33982973
    [No Abstract]   [Full Text] [Related]  

  • 44. Interferon-α-2b aerosol inhalation is associated with improved clinical outcomes in patients with coronavirus disease-2019.
    Yu J; Lu X; Tong L; Shi X; Ma J; Lv F; Wu J; Pan Q; Yang J; Cao H; Li L
    Br J Clin Pharmacol; 2021 Dec; 87(12):4737-4746. PubMed ID: 33982806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycyrrhizin for topical use and prophylaxis of COVID-19: an interesting pharmacological perspective.
    Passali D; Ciprandi G; Damiani V; De Marco AM; Cianfrone F; Passali FM
    J Biol Regul Homeost Agents; 2021; 35(1 Suppl. 2):15-19. PubMed ID: 33982533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study.
    Hatzl S; Posch F; Sareban N; Stradner M; Rosskopf K; Reisinger AC; Eller P; Schörghuber M; Toller W; Sloup Z; Prüller F; Gütl K; Pilz S; Rosenkranz AR; Greinix HT; Krause R; Schlenke P; Schilcher G
    Ann Intensive Care; 2021 May; 11(1):73. PubMed ID: 33978844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia.
    Geriak M; Haddad F; Kullar R; Greenwood KL; Habib M; Habib C; Willms D; Sakoulas G
    Infect Dis Ther; 2021 Sep; 10(3):1323-1330. PubMed ID: 33977506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluvoxamine for COVID-19?
    Med Lett Drugs Ther; 2021 May; 63(1623):69-70. PubMed ID: 33976099
    [No Abstract]   [Full Text] [Related]  

  • 49. Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study.
    Wu X; Li N; Wang G; Liu W; Yu J; Cao G; Wang J; Chen Y; Ma J; Wu J; Yang H; Mao X; He J; Yu Y; Qiu C; Li N; Yao S; Feng H; Yan J; Zhang W; Zhang J
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0035021. PubMed ID: 33972256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.
    Saunders KO; Lee E; Parks R; Martinez DR; Li D; Chen H; Edwards RJ; Gobeil S; Barr M; Mansouri K; Alam SM; Sutherland LL; Cai F; Sanzone AM; Berry M; Manne K; Bock KW; Minai M; Nagata BM; Kapingidza AB; Azoitei M; Tse LV; Scobey TD; Spreng RL; Rountree RW; DeMarco CT; Denny TN; Woods CW; Petzold EW; Tang J; Oguin TH; Sempowski GD; Gagne M; Douek DC; Tomai MA; Fox CB; Seder R; Wiehe K; Weissman D; Pardi N; Golding H; Khurana S; Acharya P; Andersen H; Lewis MG; Moore IN; Montefiori DC; Baric RS; Haynes BF
    Nature; 2021 Jun; 594(7864):553-559. PubMed ID: 33971664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease.
    Frohman EM; Villemarette-Pittman NR; Rodriguez A; Glanzman R; Rugheimer S; Komogortsev O; Zamvil SS; Cruz RA; Varkey TC; Frohman AN; Frohman AR; Parsons MS; Konkle EH; Frohman TC
    J Neurol Sci; 2021 Jul; 426():117463. PubMed ID: 33971376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic potential of megadose vitamin C to reverse organ dysfunction in sepsis and COVID-19.
    May CN; Bellomo R; Lankadeva YR
    Br J Pharmacol; 2021 Oct; 178(19):3864-3868. PubMed ID: 34061355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019.
    Xia G; Fan D; He Y; Zhu Y; Zheng Q
    Nutrition; 2021; 91-92():111405. PubMed ID: 34388587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of short-wave diathermy treatment for moderate COVID-19 patients: a prospective, double-blind, randomized controlled clinical study.
    Tian F; Wang J; Xi X; Sun X; He M; Zhao C; Feng F; Wang H; Sun W; Mao L; Hu X; Yuan H
    Eur J Phys Rehabil Med; 2022 Feb; 58(1):137-143. PubMed ID: 34042412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study.
    Augustin M; Schommers P; Stecher M; Dewald F; Gieselmann L; Gruell H; Horn C; Vanshylla K; Cristanziano VD; Osebold L; Roventa M; Riaz T; Tschernoster N; Altmueller J; Rose L; Salomon S; Priesner V; Luers JC; Albus C; Rosenkranz S; Gathof B; Fätkenheuer G; Hallek M; Klein F; Suárez I; Lehmann C
    Lancet Reg Health Eur; 2021 Jul; 6():100122. PubMed ID: 34027514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A short course of corticosteroids reduces the risk of mechanical ventilation and death in patients with moderate to severe COVID 19 pneumonia: results of a retrospective monocentric cohort.
    Comparon C; Boubaya M; Sritharan N; Dournon N; Duchemann B; Tine S; Lopez-Sublet M; Mongin M; Giroux-Leprieur B; Bloch-Queyrat C; Sigaux J; Cohen Y; Bohelay G; Caux F; Bihan H; Le Jeune S; Abad S; Levy V; Dhote R;
    Infect Dis (Lond); 2021 Oct; 53(10):779-788. PubMed ID: 34024240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-dose vitamin-C induced prolonged factitious hyperglycemia in a peritoneal dialysis patient: a case report.
    Lachance O; Goyer F; Adhikari NKJ; Masse MH; Bilodeau JF; Lamontagne F; Leclair MA
    J Med Case Rep; 2021 May; 15(1):297. PubMed ID: 34020705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG)/
    Torun S; Ozkaya S; Şen N; Kanat F; Karaman I; Yosunkaya S; Sengoren Dikis O; Asan A; Aydogan Eroglu S; Semih Atal S; Ayten O; Aksel N; Ermiş H; Özçelik N; Demirelli M; Kara I; Sümer S; Marakoğlu K; Üzer F; Uyar Y; Çiçek T; E Ünsal Z; Vatansev H; Botan Yildirim B; Kuruoğlu T; Atilla A; Ersoy Y; Kandemir B; Durduran Y; Goksin Cihan F; Demirbaş N; Yıldırım F; Tatar D; Akcay MS
    Pathog Glob Health; 2021 Sep; 115(6):405-411. PubMed ID: 34014806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients.
    Martín-Sánchez E; Garcés JJ; Maia C; Inogés S; López-Díaz de Cerio A; Carmona-Torre F; Marin-Oto M; Alegre F; Molano E; Fernandez-Alonso M; Perez C; Botta C; Zabaleta A; Alcaide AB; Landecho MF; Rua M; Pérez-Warnisher T; Blanco L; Sarvide S; Vilas-Zornoza A; Alignani D; Moreno C; Pineda I; Sogbe M; Argemi J; Paiva B; Yuste JR
    Front Immunol; 2021; 12():659018. PubMed ID: 34012444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of Xuanfei Baidu granules for treating COVID-19: A protocol for systematic review and meta-analysis.
    Zhao J; Guo D; Fan M; Liu Y
    Medicine (Baltimore); 2021 May; 100(20):e25653. PubMed ID: 34011026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.